These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8673006)

  • 1. Inhibition of platelet heparitinase by phosphorothioate DNA oligonucleotides.
    Graham LD; Mitchell SM; Underwood PA
    Biochem Mol Biol Int; 1995 Oct; 37(2):239-46. PubMed ID: 8673006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of platelet heparitinase by vascular cell lysates.
    Graham LD; Hayward IP; Underwood PA
    Biochem Mol Biol Int; 1995 Oct; 37(2):231-7. PubMed ID: 8673005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro anti-HIV activity of phosphorothioate alpha-anomeric oligodeoxynucleotides].
    Rayner B; Matsukura M; Morvan F; Cohen JS; Imbach JL
    C R Acad Sci III; 1989; 310(3):61-4. PubMed ID: 2516764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents.
    Monteith DK; Henry SP; Howard RB; Flournoy S; Levin AA; Bennett CF; Crooke ST
    Anticancer Drug Des; 1997 Jul; 12(5):421-32. PubMed ID: 9236857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3-Spacer-containing circular oligonucleotides as inhibitors of human topoisomerase I.
    Wang Y; Ng MT; Zhou T; Li X; Tan CH; Li T
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3597-602. PubMed ID: 18490159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the extent of thiolation and introduction of phosphorothioate internucleotide linkages on the anti-HIV activity of Suligovir [(s4dU)35].
    Horváth A; Beck Z; Bardos TJ; Dunn JA; Aradi J
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5321-3. PubMed ID: 16920358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
    Hatta T; Takai K; Nakada S; Yokota T; Takaku H
    Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of the HIV-1 integrase 3'-processing activity and its inhibition by phosphorothioate oligonucleotides.
    Tramontano E; Colla PL; Cheng YC
    Biochemistry; 1998 May; 37(20):7237-43. PubMed ID: 9585536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that platelet and tumour heparanases are similar enzymes.
    Freeman C; Browne AM; Parish CR
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):361-8. PubMed ID: 10455023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides.
    Mannon RB; Nataraj C; Pisetsky DS
    Cell Immunol; 2000 Apr; 201(1):14-21. PubMed ID: 10805969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptameric inhibition of in vitro DNA polymerization by phosphorothioate oligonucleotides.
    Tamura N; Iwatani W; Shoji Y; Shimada J; Mizushima Y
    Nucleic Acids Symp Ser; 1995; (34):93-4. PubMed ID: 8841568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo.
    Mata JE; Joshi SS; Palen B; Pirruccello SJ; Jackson JD; Elias N; Page TJ; Medlin KL; Iversen PL
    Toxicol Appl Pharmacol; 1997 May; 144(1):189-97. PubMed ID: 9169084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.
    Alahari SK; Dean NM; Fisher MH; Delong R; Manoharan M; Tivel KL; Juliano RL
    Mol Pharmacol; 1996 Oct; 50(4):808-19. PubMed ID: 8863825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorothioate oligodeoxynucleotides are potent sequence nonspecific inhibitors of de novo infection by HIV.
    Stein CA; Matsukura M; Subasinghe C; Broder S; Cohen JS
    AIDS Res Hum Retroviruses; 1989 Dec; 5(6):639-46. PubMed ID: 2482061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorothioate oligonucleotides: chemistry, purification, analysis, scale-up and future directions.
    Zon G; Geiser TG
    Anticancer Drug Des; 1991 Dec; 6(6):539-68. PubMed ID: 1772569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 replication by triple-helix-forming phosphorothioate oligonucleotides targeted to the polypurine tract.
    Tsukahara S; Suzuki J; Hiratou T; Takai K; Koyanagi Y; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1997 Apr; 233(3):742-7. PubMed ID: 9168925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of platelet heparitinase by tumor cell-derived factors.
    Haimovitz-Friedman A; Falcone DJ; Eldor A; Schirrmacher V; Vlodavsky I; Fuks Z
    Blood; 1991 Aug; 78(3):789-96. PubMed ID: 1859891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative activity of a triplex-forming oligonucleotide recognizing a Ki-ras polypurine/polypyrimidine motif correlates with protein binding.
    Cogoi S; Ballico M; Bonora GM; Xodo LE
    Cancer Gene Ther; 2004 Jul; 11(7):465-76. PubMed ID: 15118760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides.
    Galderisi U; Di Bernardo G; Melone MA; Galano G; Cascino A; Giordano A; Cipollaro M
    J Cell Biochem; 1999 Jul; 74(1):31-7. PubMed ID: 10381259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of different chemically modified oligodeoxynucleotides on immune stimulation.
    Zhao Q; Temsamani J; Iadarola PL; Jiang Z; Agrawal S
    Biochem Pharmacol; 1996 Jan; 51(2):173-82. PubMed ID: 8615886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.